These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20433905)

  • 1. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.
    Masliah E; Xie F; Dayan S; Rockenstein E; Mante M; Adame A; Patrick CM; Chan AF; Zheng B
    Neuroscience; 2010 Aug; 169(1):488-94. PubMed ID: 20433905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
    Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM
    J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of NgR in perforant path decreases amyloid-β peptide production and ameliorates synaptic and cognitive deficits in APP/PS1 mice.
    Jiang R; Wu XF; Wang B; Guan RX; Lv LM; Li AP; Lei L; Ma Y; Li N; Li QF; Ma QH; Zhao J; Li S
    Alzheimers Res Ther; 2020 Apr; 12(1):47. PubMed ID: 32331528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway.
    Fang Y; Wang J; Yao L; Li C; Wang J; Liu Y; Tao X; Sun H; Liao H
    J Neuroinflammation; 2018 Jul; 15(1):210. PubMed ID: 30029608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RTN/Nogo in forming Alzheimer's neuritic plaques.
    Prior M; Shi Q; Hu X; He W; Levey A; Yan R
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1201-6. PubMed ID: 20144652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.
    Kallop DY; Meilandt WJ; Gogineni A; Easley-Neal C; Wu T; Jubb AM; Yaylaoglu M; Shamloo M; Tessier-Lavigne M; Scearce-Levie K; Weimer RM
    J Neurosci; 2014 May; 34(19):6425-37. PubMed ID: 24806669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.
    Dziewczapolski G; Glogowski CM; Masliah E; Heinemann SF
    J Neurosci; 2009 Jul; 29(27):8805-15. PubMed ID: 19587288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 11. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1.
    Kume H; Murayama KS; Araki W
    J Neurosci Res; 2009 Oct; 87(13):2963-72. PubMed ID: 19405102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
    Fowler SW; Chiang AC; Savjani RR; Larson ME; Sherman MA; Schuler DR; Cirrito JR; Lesné SE; Jankowsky JL
    J Neurosci; 2014 Jun; 34(23):7871-85. PubMed ID: 24899710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative Alzheimer-like pathology in PDAPP 717V-->F transgenic mice.
    Chen KS; Masliah E; Grajeda H; Guido T; Huang J; Khan K; Motter R; Soriano F; Games D
    Prog Brain Res; 1998; 117():327-34. PubMed ID: 9932418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques.
    Koistinaho M; Ort M; Cimadevilla JM; Vondrous R; Cordell B; Koistinaho J; Bures J; Higgins LS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14675-80. PubMed ID: 11724968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology associated memory deficits in Swedish mutant genome-based amyloid precursor protein transgenic mice.
    Hock BJ; Lattal KM; Kulnane LS; Abel T; Lamb BT
    Curr Aging Sci; 2009 Dec; 2(3):205-13. PubMed ID: 20021415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice.
    Lazarov O; Lee M; Peterson DA; Sisodia SS
    J Neurosci; 2002 Nov; 22(22):9785-93. PubMed ID: 12427834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.
    Park JH; Strittmatter SM
    Curr Alzheimer Res; 2007 Dec; 4(5):568-70. PubMed ID: 18220524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca
    Yu Z; Dou F; Wang Y; Hou L; Chen H
    J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.